書誌事項
- タイトル別名
-
- CLINICAL SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR AND C-erbB-2 PROTEIN IN THE BILE DUCT CANCER
この論文をさがす
抄録
The expression of epidermal growth factor (EGFR) and c-erbB-2 protein were examined immunohistochemically in a total of 45 cases of bile duct cancer, and corelations between these expressions and clinicopathological variables were analyzed. The expression of EGFR and c-erbB-2 protein were observed in 17 of 45 cases (37.8%) respectively. There were no significant correlation between these expression and clinicopathological factors including the cell differentiation, tumor diameter, depth of invasion, lymph node involvement, stage, and vascular invasion. Five years survival rate in EGFR positive cases was 31.7% versus 61.7% in EGFR negative cases with a significant difference. Prognosis of patients with EGFR positive cancer was worse than those with EGFR negative cancer (p=0.04). Prognosis of patients with lymph node metastasis was also worse than those without lymph node metastasis (p=0.02).<br> These results suggest that expression of EGFR may serve as a useful biological marker as well as nodal involvement in the bile duct cancer.
収録刊行物
-
- 日本臨床外科医学会雑誌
-
日本臨床外科医学会雑誌 58 (7), 1468-1473, 1997
日本臨床外科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680291361024
-
- NII論文ID
- 130003600529
- 10008528440
-
- NII書誌ID
- AN00198696
-
- ISSN
- 21892075
- 03869776
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可